Arrevus Employee Directory
Biotechnology ResearchNorth Carolina, United States2-10 Employees
Arrevus is a clinical-stage biotechnology company based in Raleigh, North Carolina, focused on developing novel therapies for orphan diseases. Its work targets unmet medical needs in areas with high treatment failure rates, few therapeutic options, and serious outcomes. The company’s lead program, ARV-1801, is advancing in a Phase III clinical program to treat pulmonary exacerbations in cystic fibrosis. Beyond ARV-1801, Arrevus is pursuing preclinical programs aimed at addressing unmet needs in oncology and antimicrobial resistance. As a small biotechnology firm, its market focus centers on patients affected by rare diseases and antibiotic-resistant infections, with research aimed at advancing therapies toward clinical use. In November 2021, Arrevus was acquired by Aceragen.